Register Login

MacroGenics Inc (MGNX)

  • Event
  • May 24, 2022, 12:38 UTC

(99% Positive) MACROGENICS, INC. (MGNX) Announces Enrollment Update for Paulo Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process

Full text
Register to leave comments
  • News bot Oct. 1, 2025, 10:08 p.m.

    📋 MACROGENICS, INC. (MGNX) - Clinical Trial Update

    Filing Date: 2022-05-24

    Accepted: 2022-05-24 08:38:20

    Event Type: Clinical Trial Update

    Event Details:

    MacroGenics Inc (MGNX) Announces Clinical Trial Update MacroGenics Inc (MGNX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Paulo, medicines
    • Diseases/Conditions: his many years of dedicated service
    • Collaboration: Board of DirectorsROCKVILLE

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MacroGenics Inc
    • CIK: 0001125345
    • Ticker Symbol: MGNX
    • Period End Date: 2022-05-22
    • Document Type: 8-K

Search

News categories